Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Diet and exercise may cut heart risks for breast cancer patients on hormone therapy

NCT ID NCT07443787

Disease control Sponsor: MOHAMEDI Ilhem Sarra Manel Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study looked at whether a Mediterranean diet and increased physical activity could improve heart health in 150 breast cancer survivors taking hormone therapy. Participants received counseling on diet and exercise over three months. Researchers measured changes in waist size, weight, blood pressure, and cholesterol to see if the lifestyle program reduced heart disease risk.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Mediterranean diet and physical activity promotion
What this could lead to
If successful, this could show that lifestyle changes help manage heart disease risk in breast cancer survivors on hormone therapy.
What could go wrong
This is a small, completed study without a control group, so results may not be definitive or apply to all patients. Lifestyle changes can be hard to maintain long-term.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

150 people

The number who actually took part.

Started

May 2022

Finished

Jun 2025

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 to 75 years

Sex

Female participants only

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Histologically confirmed hormone receptor-positive breast cancer * Breast cancer survivors receiving adjuvant endocrine therapy (tamoxifen or aromatase inhibitors) for ≥3 months * No recurrence or second primary malignancy * Ability to perform moderate-intensity physical activity * Consecutively recruited during routine surveillance visits Exclusion Criteria: * Incomplete or discontinued hormone therapy * Concurrent ovarian suppression * Use of lipid-lowering medications * Severe uncontrolled comorbidities (e.g., diabetes, cardiac, or hepatic disease) * Cognitive or physical impairments preventing informed consent or participation * Restrictive dietary regimens

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Breast cancer are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

breast cancer cardiovascular disorder Motor Activity

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Cardiovascular diseases

Contacts and locations

Locations

  • Akid Othmane Hospital

    Oran, Aïn-El-Turck, 31300, Algeria

More trials for these conditions

Other studies related to the condition(s) this trial covers.